While this suggests that the cancer cells have a potential path to immune escape, the EGFRvIII+ cancer cells are more resistant to chemotherapeutic agents such as paclitaxel and cisplatin [9] and a subclonal population of EGFRvIII+ cells can promote survival of EGFR wt neighbors [11]. The gene discussed is EGFR; the disease is cancer.